HomeTNYA • NASDAQ
add
Tenaya Therapeutics Inc
Previous close
$0.44
Day range
$0.42 - $0.45
Year range
$0.36 - $4.67
Market cap
72.69M USD
Avg Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.54M | -18.43% |
Net income | -26.86M | 16.64% |
Net profit margin | — | — |
Earnings per share | -0.24 | 40.00% |
EBITDA | -24.88M | 21.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.16M | -27.89% |
Total assets | 143.95M | -22.15% |
Total liabilities | 24.56M | -8.10% |
Total equity | 119.40M | — |
Shares outstanding | 162.67M | — |
Price to book | 0.60 | — |
Return on assets | -52.18% | — |
Return on capital | -57.67% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -26.86M | 16.64% |
Cash from operations | -23.11M | 19.36% |
Cash from investing | 22.30M | 596.81% |
Cash from financing | 50.26M | 7.46% |
Net change in cash | 49.45M | 263.01% |
Free cash flow | -13.44M | 25.82% |
About
Founded
2016
Headquarters
Website
Employees
97
